Sign up to save your podcasts
Or
Share Desfechos e fatores prognósticos no carcinoma lobular invasivo triplo-negativo (TN) e ctDNA na doença luminal e TN
Share to email
Share to Facebook
Share to X
Share to email
Share to Facebook
Share to X
Or
Desfechos e fatores prognósticos no carcinoma lobular invasivo triplo-negativo (TN) e ctDNA na doença luminal e TN
Referências:
triple-negative invasive lobular carcinoma of the breast. Breast Cancer Res
Treat 200, 217–224 (2023). https://doi.org/10.1007/s10549-023-06959-3
ou https://link.springer.com/article/10.1007/s10549-023-06959-3
Hirst GL, Yau C, Wolf DM, Li W, Delson AL, Asare S, Liu MC, Albain K, Chien AJ,
Forero-Torres A, Isaacs C, Nanda R, Tripathy D, Rodriguez A, Sethi H, Aleshin
A, Rabinowitz M, Perlmutter J, Symmans WF, Yee D, Hylton NM, Esserman LJ,
DeMichele AM, Rugo HS, van 't Veer LJ. Clinical significance and biology of circulating tumor DNA in high-risk
early-stage HER2-negative breast cancer receiving neoadjuvant chemotherapy.
Cancer Cell. 2023 Jun 12;41(6):1091-1102.e4. doi: 10.1016/j.ccell.2023.04.008.
Epub 2023 May 4. PMID: 37146605. https://www.cell.com/cancer-cell/fulltext/S1535-6108(23)00134-4
View all episodes
By onconewsReferências:
triple-negative invasive lobular carcinoma of the breast. Breast Cancer Res
Treat 200, 217–224 (2023). https://doi.org/10.1007/s10549-023-06959-3
ou https://link.springer.com/article/10.1007/s10549-023-06959-3
Hirst GL, Yau C, Wolf DM, Li W, Delson AL, Asare S, Liu MC, Albain K, Chien AJ,
Forero-Torres A, Isaacs C, Nanda R, Tripathy D, Rodriguez A, Sethi H, Aleshin
A, Rabinowitz M, Perlmutter J, Symmans WF, Yee D, Hylton NM, Esserman LJ,
DeMichele AM, Rugo HS, van 't Veer LJ. Clinical significance and biology of circulating tumor DNA in high-risk
early-stage HER2-negative breast cancer receiving neoadjuvant chemotherapy.
Cancer Cell. 2023 Jun 12;41(6):1091-1102.e4. doi: 10.1016/j.ccell.2023.04.008.
Epub 2023 May 4. PMID: 37146605. https://www.cell.com/cancer-cell/fulltext/S1535-6108(23)00134-4